Noa-Suárez D, Vázquez-Balart L

Language: Spanish
References: 17
Page: 1-12
PDF size: 308.25 Kb.

ABSTRACT

Introduction: an increase in the number of drug-resistant tuberculosis patients has been observed in the last 10 years in Cuba and, especially, in Guantánamo province. This is the province with the highest incidence in the country.
Objective: to identify the epidemiological characteristics and the resistance pattern of drug-resistant tuberculosis in Guantánamo province.
Method: a descriptive, cross-sectional study was designed that included all cases (n=6) with drug-resistant tuberculosis, diagnosed between December 2010 and December 2019. The variables studied were: age, gender, therapeutic regimen, economic situation, categories of cases, epidemiological classification of resistance, and resistance of the isolated strain according to the grade and profile.
Results: males predominated (66.6%), and also the age group under 45 years (83.3%), the greatest resistance was caused by not abiding the previous treatments (66.6%), categorized mostly as chronic, and readmitted due to treatment abandonment. Highschool degree (66.7%) predominated, with a moderate economic situation (50.0%) and high levels of alcoholism (66.7%). Multi-drug resistance prevailed in the strains in patients with previous treatment (66.6%).
Conclusions: there is a coincidence of the epidemiological pattern and the resistance pattern shown in the current research with the results of previous national and international studies; these results suggest flaws in the local application of the Programa Nacional de Control y Tratamiento de la tuberculosis. It is recommended to investigate and resolve these flaws, which would have an immediate impact on reducing the incidence of drug-resistant tuberculosis.

REFERENCES

1. World Health Organization. Tuberculosis [Internet]. Ginebra: WHO; 2020 [citado 17 Jun 2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/tuberculosis

2. World Health Organization. Global Tuberculosis Report [Internet]. Geneva: WHO; 2020. [citado 17 Jun 2021]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf

3. Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis [Internet]. 2020 [citado 17 Jun 2021]; 2010 Apr; 14(4):382-90. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20202293/

4. Tierney D, Nardell EA. Tuberculosis - Enfermedades infecciosas [Internet]. USA: Manual MSD; 2021. [citado 17 Jun 2021]. Disponible en: https://www.msdmanuals.com/es/professional/enfermedades-infecciosas/micobacterias/tuberculosis

5. Nachega JB, Chaisson RE. Tuberculosis drug resistance: a global threat. Clinical Infectious Diseases. 2018; 36:24–30.

6. Enfermedad de tuberculosis (TB): Síntomas y factores de riesgo [Internet], 2020 [citado 17 Jun 2021]. Disponible en: https://www.cdc.gov/spanish/especialescdc/sintomastuberculosis/index.html

7. Frieden TR, Khatri GR. Multi-drug resistant tuberculosis. In: Narain JP. Tuberculosis epidemiology and control. WHO/SEA/TB/248. New Delhi: World Health Organization Regional Office for South-East Asia; 2018. p: 105-115.

8. Caminero Luna JA. Guía de la Tuberculosis para Médicos Especialistas. Francia: Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias; 2003. [citado 17 Jun 2021]. Disponible en: https://es.scribd.com/doc/91018773/La-Tuberculosis-para-Medicos-Especialistas-Gu%C4%B1a

9. Tuberculosis. Medlineplus.gov; 2020 [citado 17 Jun 2021]. Disponible en: https://medlineplus.gov/spanish/tuberculosis

10. Tuberculosis (TB): Causes, symptoms and treatments. www.medicalnewstoday.com; 2020. [citado 17 Jun 2021]. Disponible en: https://www.medicalnewstoday.com/articles

11. Tuberculosis - Diagnóstico y tratamiento - Mayo Clinic. https://www.mayoclinic.org; 2021. [citado 17 Jun 2021]. Disponible en: https://www.mayoclinic.org/es-es/diseases conditions/tuberculosis/diagnosis-treatment

12. Calvo Bonachera J, Bernal Rosique MS. Tuberculosis. Diagnóstico y tratamiento. En: Neumosur [Internet]. España: Asociación de Neumología y Cirugía Torácica del Sur; 2021 [citado 17 Jun 2021]. Disponible en: https://www.neumosur.net/files/EB03-43%20TBC%20dco%20tto.pdf

13. Marrero A, Carreras L, Valdivia JA, Montoro E, González E, et al. Manual de Normas y Procedimientos. La Habana: Ciencias Médicas Cuba; 2019.

14. Dirección Nacional de Estadística. Anuario Estadístico de Salud 2017 [Internet]. La Habana: MINSAP; 2018 [citado 25 Jun 2021]. Disponible en: https://files.sld.cu/gericuba/files/2018/11/Anuario-Electronico-Espa%c3%b1ol-2017-ed-20181.pdf

15. Aiza Alvarez T, Palmeira Rodrigues M, Viegas CA. Prevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatment. J Bras Pneumol [Internet]. 2019 Jun [citado 25 Jun 2021]; 35(6):555-560. DOI: https://doi.org/10.1590/s1806-37132009000600009

16. Montoro E, Echemendía M, Lemus D, Marrero A, Llanes MJ, Valdivia JA. Vigilancia de la resistencia de Mycobacterium tuberculosis a las drogas antituberculosas en Cuba, 1995-1998. Biomédica [Internet]. 2019 [citado 25 Jun 2021]; 24(Supl):80-84. DOI: https://doi.org/10.7705/biomedica.v24iSupp1.1306

17. Montoro E, Lemus D, Echemendia M, Diaz R, Mederos L, Martinez MR, et al. Vigilancia de la resistencia a los fármacos antituberculosos en Cuba, 2000-2009. Rev Panam Salud Púb [Internet]. 2011 [citado 25 Jun 2021]; 30(6):615-8. Disponible en: https://www.scielosp.org/article/rpsp/2011.v30n6/615-618/